Michael Hall

Michael Hall, MD has diverse work experience in the pharmaceutical industry. Michael currently holds the position of Senior Vice President of Clinical & Medical Affairs / Head of Development at Zealand Pharma A/S. Prior to this, they served as Senior Vice President of Clinical Affairs at Ironwood Pharmaceuticals from 2013 to 2018. Michael was also the Chief Medical Officer at Repligen Corporation from 2011 to 2013. Dr. Hall has a strong background in clinical affairs, evidenced by their role as Vice President of Clinical Affairs at Shire Human Genetic Therapies Inc from 2005 to 2009. Michael began their career as an Executive Director at Novartis Pharmaceuticals Corporation in 1991, where they held the position until 2005. Overall, Dr. Hall has a wealth of experience in various leadership roles within the pharmaceutical industry.

Michael Hall, MD attended the University of the Witwatersrand where they obtained their MBBCh (MD) degree in Medicine in 1988.